{
  "actions": [
    {
      "acted_at": "2001-07-11T17:27:00-04:00", 
      "references": [
        {
          "reference": "CR H3921-3922", 
          "type": "consideration"
        }, 
        {
          "reference": "H3921", 
          "type": null
        }
      ], 
      "text": "Amendment (A032) offered by Mr. Allen.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-07-11T17:33:00-04:00", 
      "references": [], 
      "text": "Mr. Bonilla raised a point of order against the Allen amendment (A032). Mr. Bonilla stated that the amendment sought to change existing law and constituted legislation in an appropriation bill. The Chair sustained the point of order.", 
      "type": "action"
    }
  ], 
  "amendment_id": "hamdt164-107", 
  "amendment_type": "hamdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "hr2330-107", 
    "bill_type": "hr", 
    "congress": 107, 
    "number": 2330
  }, 
  "amends_treaty": null, 
  "chamber": "h", 
  "congress": "107", 
  "description": null, 
  "house_number": 32, 
  "introduced_at": "2001-07-11", 
  "number": 164, 
  "purpose": "An amendment numbered 4 printed in the Congressional Record to prohibit use of funds for approval of new drug applications without disclosure of the cost of research and development of such new drug and what portion of that cost is made up with public funding.", 
  "sponsor": {
    "district": "1", 
    "name": "Allen, Thomas H.", 
    "state": "ME", 
    "thomas_id": "01461", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "offered", 
  "status_at": "2001-07-11", 
  "updated_at": "2013-07-17T08:15:54-04:00"
}